Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    -0.50 (-2.27%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

10 Nov 2020 07:00

RNS Number : 7364E
Checkit PLC
10 November 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

10 November 2020

 

Checkit plc

("Checkit" or the "the Group")

 

Trading update

 

The Group provides a trading update for the nine months to 31 October 2020. A summary of the Group's unaudited Revenue for the three months to October 2020 ("Q3 FY21") and year to date is as follows:

 

REVENUES (UNAUDITED) (£m)

Three months to

Nine months to

 

 

 

31 Oct

2020 Actual

31 Oct

2019

Actual

Change

%

31 Oct

2020 Actual

31 Oct 2019

Actual

31 Oct 2019

Normalised*

Change Normalised*

%

Checkit Connect:

Recurring

1.3

1.0

+30%

3.6

2.2

2.9

+24%

Non-recurring

0.3

0.5

(40) %

1.4

1.0

1.5

(7) %

Total Checkit Connect

1.6

1.5

+7%

5.0

3.2

4.4

+14%

Total Checkit BEMS

1.8

1.9

(5) %

4.8

3.4

5.2

(8) %

  (Non - recurring)

Total Group

3.4

3.4

0%

9.8

6.6

9.6

+2%

 

* Normalised sales illustrate sales that would have been included in the Group's financial results had Checkit UK Limited, which was acquired on 14 May 2019, been owned by the Group throughout both periods.

 

The business performed ahead of the Board's expectations during Q3 FY21.

 

The period saw an improvement in the Checkit BEMS revenue run rate compared to Q2, as government restrictions eased and field engineers returned to customer sites for installation projects. A first half slowdown in sales of lower margin installation business (due to COVID-19) resulted in a 5% decline in the Checkit BEMs revenue line compared to the prior period.

 

Checkit Connect Recurring revenues for Q3 FY21 grew 30% compared to the prior period, continuing the trend reported in the Group's interim results. During the period there were further conversions of existing annual calibration and maintenance contracts into subscription-based income.

 

Cash

Cash at 31 October 2020 was £12.4m (31 January 2020: £14.3m; 31 July 2020: £13.4m).

 

Outlook

The Board continues to monitor the situation in view of the current uncertainties but remains confident in the medium and long term opportunities for the business.

 

Forward looking statements

This document contains forward looking statements with respect to the business, strategy and plans of Checkit plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Checkit or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Checkit's actual future results may differ materially from the results expressed or implied in these forward looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. The forward looking statements contained in this document are made as of the date hereof, and Checkit undertakes no obligation to update any of its forward looking statements

 

 Checkit plc +44 (0) 1223 371000

 www.checkit.net

 Keith Daley (Executive Chair)

 Aylsa Muir (Chief Financial Officer)

 

 

 N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000

 Shaun Dobson / George Tzimas (Corporate Finance)

 Rachel Hayes (Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRBDBCDGDGGC
Date   Source Headline
17th Apr 20242:35 pmRNSNotice of Results and Investor Presentation
15th Apr 20247:00 amRNSNew Product Launch and Contract Wins
14th Mar 20248:49 amRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSGrant of Options and PDMR Dealings
8th Mar 20249:00 amRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSInvestor Presentation
1st Feb 20242:25 pmRNSSurrender of Existing Options
7th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSInvestor Presentation
10th Aug 20237:00 amRNSTrading update notice of results & contract
8th Jun 20234:08 pmRNSResult of AGM
24th May 20233:29 pmRNSDirector/PDMR Shareholding
15th May 20231:04 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20237:00 amRNSPreliminary Results
13th Apr 20231:36 pmRNSNotice of Results and Investor Presentation
23rd Mar 20235:25 pmRNSDirector/PDMR Shareholding
13th Mar 20238:55 amRNSStatement re. Silicon Valley Bank
16th Feb 20237:00 amRNSTrading Update and Notice of Results
26th Jan 20234:10 pmRNSDirectorate Change
23rd Jan 20237:00 amRNSDirector/PCA Dealing
10th Jan 20237:00 amRNSAppointment of Non-Executive Director
10th Jan 20237:00 amRNSGrant of options and PDMR dealings
5th Jan 20237:00 amRNSContract wins and investor presentation
12th Dec 20225:14 pmRNSDirector/PDMR Shareholding
27th Sep 202212:28 pmRNSHolding(s) in Company
23rd Sep 20226:16 pmRNSDirector/PDMR Shareholding
16th Sep 20225:36 pmRNSDirector Dealing
15th Sep 20227:00 amRNSInterim Results
6th Sep 20227:00 amRNSInvestor Presentation
22nd Aug 20221:07 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSTrading Update and Notice of Interim Results
9th Jun 20223:09 pmRNSResult of AGM
13th May 20225:17 pmRNSPosting of Annual Report and Notice of AGM
13th May 20227:00 amRNSInvestor Conference
4th May 20227:00 amRNSContract Renewal
28th Apr 20227:00 amRNSPreliminary Results
29th Mar 20227:00 amRNSGrant of options and PDMR dealings
23rd Feb 20227:00 amRNSPDMR Dealing
22nd Feb 20227:00 amRNSPDMR Dealing
17th Feb 20227:00 amRNSTrading update
1st Feb 20227:00 amRNSContract win
22nd Dec 20212:06 pmRNSHolding(s) in Company
20th Dec 20217:01 amEQSCheckit (CKT): SaaS software for the deskless workforce
17th Dec 20212:44 pmRNSDirector/PDMR Shareholding
16th Dec 202111:52 amRNSResult of General Meeting and Admission
2nd Dec 202111:00 amRNSHolding(s) in Company
2nd Dec 202111:00 amRNSHolding(s) in Company
29th Nov 202111:44 amRNSPosting of Circular and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.